Literature DB >> 30249715

Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?

Parviz Sorooshian1, Timothy A C Snow2,3.   

Abstract

Keywords:  intensive care; therapeutic drug monitoring

Mesh：

Substances：

Year:  2018        PMID： 30249715      PMCID： PMC6153834          DOI： 10.1128/AAC.01209-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.

Authors:  Anna Silva Machado; Maura S Oliveira; Cristina Sanches; Carlindo Vieira da Silva Junior; David S Gomez; Rolf Gemperli; Silvia Regina Cavani Jorge Santos; Anna S Levin
Journal:  Clin Ther       Date:  2017-07-10       Impact factor: 3.393

Review 2.  Prolonged vs intermittent infusion of piperacillin/tazobactam in critically ill patients: a narrative and systematic review.

Authors:  Erlangga Yusuf; Herbert Spapen; Denis Piérard
Journal:  J Crit Care       Date:  2014-08-07       Impact factor: 3.425

3.  An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.

Authors:  Gloria Wong; Alexander Brinkman; Russell J Benefield; Mieke Carlier; Jan J De Waele; Najoua El Helali; Otto Frey; Stephan Harbarth; Angela Huttner; Brett McWhinney; Benoit Misset; Federico Pea; Judit Preisenberger; Michael S Roberts; Thomas A Robertson; Anka Roehr; Fekade Bruck Sime; Fabio Silvio Taccone; Jacobus P J Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  J Antimicrob Chemother       Date:  2014-01-16       Impact factor: 5.790

4.  Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.

Authors:  Jan J De Waele; S Carrette; M Carlier; V Stove; J Boelens; G Claeys; I Leroux-Roels; E Hoste; P Depuydt; J Decruyenaere; A G Verstraete
Journal:  Intensive Care Med       Date:  2013-12-20       Impact factor: 17.440

5.  Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model.

Authors:  Iris K Minichmayr; Jason A Roberts; Otto R Frey; Anka C Roehr; Charlotte Kloft; Alexander Brinkmann
Journal:  J Antimicrob Chemother       Date:  2018-05-01       Impact factor: 5.790

6.  Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care Unit.

Authors:  P Voirol; Y-A Que; A Fournier; P Eggimann; O Pantet; J L Pagani; E Dupuis-Lozeron; A Pannatier; F Sadeghipour
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

7.  Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.

Authors:  Anne Fournier; Philippe Eggimann; Jean-Luc Pagani; Jean-Pierre Revelly; Laurent A Decosterd; Oscar Marchetti; André Pannatier; Pierre Voirol; Yok-Ai Que
Journal:  Burns       Date:  2015-02-10       Impact factor: 2.744

8.  Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.

Authors:  Susanna Edith Medellín-Garibay; Silvia Romano-Moreno; Pilar Tejedor-Prado; Noelia Rubio-Álvaro; Aida Rueda-Naharro; Miguel Angel Blasco-Navalpotro; Benito García; Emilia Barcia
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191
  8 in total
  1 in total

1.  Reply to Sorooshian and Snow, "Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?"

Authors:  A Fournier; P Eggimann; O Pantet; J L Pagani; E Dupuis-Lozeron; A Pannatier; F Sadeghipour; P Voirol; Y-A Que
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.